---
title: "Norgestrel - Menorrhagia"
sidebar: mydoc_sidebar
permalink: norgestrelmenorrhagia.html
toc: false 
---

{% include image.html url="images/norgestrelmenorrhagia.png" file="norgestrelmenorrhagia.png" alt="norgestrelmenorrhagia" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D009644 | Norgestrel | Drug |
| UniProt:P06401 | Progesterone receptor | Protein |
| GO:0050673 | Epithelial cell proliferation | BiologicalProcess |
| MESH:D008595 | Menorrhagia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Norgestrel | INCREASES ACTIVITY OF | Progesterone Receptor |
| Progesterone Receptor | NEGATIVELY REGULATES | Epithelial Cell Proliferation |
| Epithelial Cell Proliferation | POSITIVELY CORRELATED WITH | Menorrhagia |
|---------|-----------|---------|

Comment: Norgestrel is composed of a racemic mixture of two stereoisomers, dextronorgestrel and levonorgestrel. However, only the levorotary enantiomer (levonorgestrel) is biologically active. There is an evidence indicating that levonorgestrel activates progesteron receptor [https://pubmed.ncbi.nlm.nih.gov/16112947/](https://pubmed.ncbi.nlm.nih.gov/16112947/)

Reference: [https://go.drugbank.com/drugs/DB09389#mechanism-of-action](https://go.drugbank.com/drugs/DB09389#mechanism-of-action){:target="_blank"}